MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : BIOTECH
FATE THERAPEUTICS INC

Fate Therapeutics Inc XNAS: FATE

1.33 0.00 (0.00%)

31.44% Fall from 52W High

1.4M

XNAS Volume

XNAS 09 Mar, 2026 5:30 PM (EDT)

Board Meeting

The latest board meeting for Fate Therapeutics Inc took place on 09 Mar 2026, for the purpose of Leerink Partners 2026 Global Healthcare Conference See details

Fate Therapeutics Inc - FATE - stock price prediction, stock price target, analyst ratings from 12 analysts

Fate Therapeutics Inc has a share price target of US$ 5, revenue growth forecast of -21.7%, and profit growth estimate of -2.7% for FY26, based on top 12 analyst calls.

31.44% Fall from 52W High

Fate Therapeutics Inc - FATE - stock price prediction, stock price target, analyst ratings from 12 analysts

Fate Therapeutics Inc has a share price target of US$ 5, revenue growth forecast of -21.7%, and profit growth estimate of -2.7% for FY26, based on top 12 analyst calls.

Forecaster Screeners